NICE would welcome further discussions about access to spinal muscular atrophy drug nusinersen
NICE hopes for further talks over nusinersen for treating a rare genetic disorder; spinal muscular atrophy (SMA).
NICE guideline set to address variation in provision of services for adults with cerebral palsy
NICE has published a draft guideline on the care and support adults with cerebral palsy should receive.
Launch of new master’s degree in Evaluation of Health Care Interventions and Outcomes
A new master’s degree in healthcare decision making has been launched by London School of Economics and Political Science (LSE) in collaboration with NICE.
Cancer drug for children recommended after becoming cost effective for NHS patients
Around 60% of children with high-risk neuroblastoma could be treated with dinutuximab beta
Latest news headlines
-
More people to be given dye to highlight brain tumours to surgeons say NICE
Hundreds of patients a year set to benefit from roll out of dye to all of England’s neurosurgical units
10 July 2018
-
Antibiotics should be restricted for COPD
Healthcare professionals should consider the risk of antimicrobial resistance when deciding whether antibiotics are needed for treating or preventing a flare up of symptoms of chronic obstructive pulmonary disease (COPD).
09 July 2018
-
NICE renews major health improvement partnership with Greater Manchester
A major collaboration between NICE and Greater Manchester has been secured for a further three years, until June 2021.
25 June 2018
-
People with dementia should be involved in discussions about their care, says NICE
NICE has updated its guidance for the support of people living with dementia.
20 June 2018
-
NICE backed award for physiotherapist helping to improve patients’ quality of life
Laura McNeillie picks up NICE award at Chief Allied Health Professions Officer’s awards
20 June 2018
-
Adding pertuzumab to existing treatments after surgery for early breast cancer not cost effective, says NICE in draft guidance
Women with a type of early breast cancer may not benefit from continuing or starting a drug after having surgery, NICE says in draft guidance.
15 June 2018